Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma
Author / Expert
Brian T. Hickner, Andres F. Espinoza, Prakash M. Masand, Dolores H. Lopez-Terrada, Valeria R. Smith, Sarah S. Kappa, Ekene A. Onwuka, Jed G. Nuchtern, Sanjeev A. Vasudevan
Abstract
Surgery is the cornerstone of therapy for hepatoblastoma (HB). While standard resection (SR) via hemi-hepatectomy and trisectionectomy has traditionally been the preferred surgical approach, parenchyma-sparing resection (PSR) has become increasingly popular. We sought to compare the characteristics and outcomes of patients who underwent PSR versus SR.
Keywords
Hashtags
This article is published on an external journal. Click below to read the full text.
Read full article ↗How to cite: Brian T. Hickner, Andres F. Espinoza, Prakash M. Masand, Dolores H. Lopez-Terrada, Valeria R. Smith, Sarah S. Kappa, Ekene A. Onwuka, Jed G. Nuchtern, Sanjeev A. Vasudevan. Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma. GlobalCastMD Medical Library. 2026-05-05. http://library.globalcastmd.com/article/12001
Comments (0)